Are we there yet? Closing the gender gap in coronary heart disease recognition, management and outcomes

Expert Review of Cardiovascular Therapy

Volumn 11, Issue 11, 2013, Pages 1447-1450

  Wenger, Nanette K ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute coronary syndromes; cardiovascular disease; coronary heart disease; coronary revascularization; gender gap; prevention guideline; risk factors; women

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; BARE METAL STENT; BLEEDING; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DIABETES CONTROL; DRUG ELUTING STENT; EXERCISE TEST; HEALTH CARE POLICY; HEALTH DISPARITY; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROPHYLAXIS; REVIEW; SECONDARY PREVENTION; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WOMEN'S HEALTH;

CORONARY DISEASE; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SEX FACTORS;

EID: 84887386300     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2013.845526     Document Type: Review

References (27)

1. Go AS, Mozaffarian D, Roger VL et al. Heart Disease and Stroke statistics-2013 update: A report from the American Heart Association. Circulation 127 (1), e6-e245, (2013
2. Ford ES, Capewell S. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: Concealed leveling of mortality rates. J. Am. Coll. Cardiol. 50(22), 2128-2132 (2007
3. Committee on Women's Health. Board on Population Health and Public Health Practices. Women's Health Research. Progress, Pitfalls, and Promise. Institute of Medicine, National Academies Press, Washington, DC, USA (2013
4. Mosca L, Benjamin EJ, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation 123(11), 1243-1262 (2011
5. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results of the Women's Health Initiative randomized controlled trial. JAMA 288(3), 321-333 (2002
6. Wassertheil-Smoller S, Hendrix SL, Limacher M et al. WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: A randomized trial. JAMA 289(20), 2673-2684 (2003
7. Moyer VA; U.S. Preventive Services Task Force. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 158(1), 47-54 (2013
8. Cook NR, Albert CM, Gaziano JM et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: Results from the Women's Antioxidant Cardiovascular Study. Arch. Intern. Med. 167(15), 1610-1618 (2007
9. Albert CM, Cook NR, Gaziano JM et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 299(17), 2027-2036 (2008
10. Lonn E, Yusuf S, Arnold MJ et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354(15), 1567-1577 (2006
11. Clarke R, Halsey J, Lewington S et al. B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-Analysis of 8 randomized trials involving 37,485 individuals. Arch. Intern. Med. 170(18), 1622-1631 (2010
12. Manson JE, Vitamin D and the heart: Why we need large-scale clinical trials. Cleve. Clin. J. Med. 77(12), 903-910 (2010
13. Hsai, J, Heiss G, Ren H et al. Women's Health Initiative Investigators. Calcium/ vitamin D supplementation and cardiovascular events. Circulation 115(7), 846-854 (2007
14. Ridker PM, Cook NR, Lee I-M et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N. Engl. J. Med. 352(13), 1293-1304 (2005
15. U.S. Preventive Services Task Force. Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 150(6), 396-404 (2009
16. Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358(22), 2345-2359 (2008
17. Ridker P, Danielson E, Fonseca FAH et al. JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N. Engl. J. Med. 359(21), 2195-2207 (2008
18. Kaul S, Morrissey RP, Diamond GA. By Jove! What is a clinician to make of JUPITER? Arch. Intern. Med. 170(12), 1073-1077 (2010
19. Mannisto J, Mendola P, Vaarasmaki M et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation 127(6), 681-690 (2013
20. Udell JA, Lu H, Redelmeier DA. Long-Term cardiovascular risk in women prescribed fertility therapy. J. Am. Coll. Cardiol. doi:10:1016/j.jacc.2013.05. 085 (2013) (Epub ahead of print
21. Canto AJ, Kiefe CI, Goldberg RJ et al. Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. Am. Heart J. 163(4), 572-579 (2012
22. Berger JS, Elliott L, Gallup D et al. Sex differences in mortality following acute coronary syndromes. JAMA 302(8), 874-882 (2009
23. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction. Arch. Intern. Med. 169(19), 1767-1774 (2009
24. Wenger NK. Women and coronary heart disease: A century after Herrick. Understudied, underdiagnosed, and undertreated. Circulation 126(5), 604-611 (2012
25. Stefanini GG, Baber U, Windecker S et al. Safety and efficacy of drug-eluting stents in women: A patient-level pooled analysis of randomised trials. Lancet doi:10.1016/ S0140-6736(13)61782-1 (2013) (Epub ahead of print
26. Puskas JD, Kilgo PD, Kutner M, Pusca SV, Lattouf O, Guyton RA. Off-pump techniques disproportionately benefit women and narrow the gender disparity in outcomes after coronary artery bypass surgery. Circulation 116(Suppl. 1), I192-I199 (2007
27. Geller SE, Koch A, Pellettieri B, Carnes M Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress? J. Womens Health 20(3), 315-320 (2011